ERBB2 and breast cancer: After considering the original objective of this study, it is now possible to state that this finding yielded valuable insights into the link between metabolic processes and glycaemic conditions in BC, specifically the luminal-A (ER+/PR+/−/HER2−) subtype, as well as the significant impact of PEDF on metabolic pathways.